Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Research Network

Collaboration Network

21 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

State University of New York - Upstate Medical University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Aminah Jatoi, MD

Mayo Clinic

Moderately Similar
29 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)
Similarity Score30%

Edward G. Shaw, MD

Wake Forest University Health Sciences

Moderately Similar
12 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

National Cancer Institute (NCI)North Central Cancer Treatment Group+2 more
Similarity Score30%

Alex A. Adjei, MD, PhD

Roswell Park Cancer Institute

Related
5 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Alliance for Clinical Trials in OncologyCancer and Leukemia Group B+4 more
Collaborated on 1 trial
Similarity Score24%

Hak Choy, MD

Simmons Cancer Center

Related
5 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Mark Dobelbower, MD PhD

University of Alabama Medical Center

Related
1 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Gregory A. Masters, MD

CCOP - Christiana Care Health Services

Related
1 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Steven E. Schild, MD

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Alliance for Clinical Trials in OncologyCancer and Leukemia Group B+4 more
Collaborated on 1 trial
Similarity Score24%

Tien Hoang, MD

University of Wisconsin, Madison

Related
2 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Jeff Sloan, PhD, HSR

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Ken Forster, PhD

H. Lee Moffitt Cancer Center

Related
1 trials

Shared therapeutic areas:

Lung CancerRadiation Toxicity

Worked with same sponsors:

Cancer and Leukemia Group BNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00632853Phase 3StudyChair

Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

Lung Cancer
Completed
NCT00533949Phase 3StudyChair

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Lung CancerRadiation Toxicity
Completed

All 2 trials loaded